296 related articles for article (PubMed ID: 11097225)
1. Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women.
Maciag PC; Schlecht NF; Souza PS; Franco EL; Villa LL; Petzl-Erler ML
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1183-91. PubMed ID: 11097225
[TBL] [Abstract][Full Text] [Related]
2. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.
Hildesheim A; Schiffman M; Scott DR; Marti D; Kissner T; Sherman ME; Glass AG; Manos MM; Lorincz AT; Kurman RJ; Buckland J; Rush BB; Carrington M
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1035-41. PubMed ID: 9829713
[TBL] [Abstract][Full Text] [Related]
3. Human leukocyte antigen class II and cervical cancer risk: a population-based study.
Madeleine MM; Brumback B; Cushing-Haugen KL; Schwartz SM; Daling JR; Smith AG; Nelson JL; Porter P; Shera KA; McDougall JK; Galloway DA
J Infect Dis; 2002 Dec; 186(11):1565-74. PubMed ID: 12447731
[TBL] [Abstract][Full Text] [Related]
4. Human leukocyte antigen class II alleles and risk of cervical cancer in China.
Wu Y; Liu B; Lin W; Xu Y; Li L; Zhang Y; Chen S; Lin Z; Xu A
Hum Immunol; 2007 Mar; 68(3):192-200. PubMed ID: 17349874
[TBL] [Abstract][Full Text] [Related]
5. HLA polymorphisms and cervical human Papillomavirus infection in a cohort of Montreal University students.
Mahmud SM; Robinson K; Richardson H; Tellier PP; Ferenczy AS; Roger M; Coutlee F; Franco EL
J Infect Dis; 2007 Jul; 196(1):82-90. PubMed ID: 17538887
[TBL] [Abstract][Full Text] [Related]
6. HLA class II DR-DQ and increased risk of cervical cancer among Senegalese women.
Lin P; Koutsky LA; Critchlow CW; Apple RJ; Hawes SE; Hughes JP; Touré P; Dembele A; Kiviat NB
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1037-45. PubMed ID: 11588129
[TBL] [Abstract][Full Text] [Related]
7. DQA1 and DQB1 genes in patients with squamous cell carcinoma of the cervix: relationship to human papillomavirus infection and prognosis.
Helland A; Børresen AL; Kristensen G; Rønningen KS
Cancer Epidemiol Biomarkers Prev; 1994 Sep; 3(6):479-86. PubMed ID: 8000298
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of the human leukocyte antigen DRB1 and DQB1 genes and the natural history of human papillomavirus infection.
Maciag PC; Schlecht NF; Souza PS; Rohan TE; Franco EL; Villa LL
J Infect Dis; 2002 Jul; 186(2):164-72. PubMed ID: 12134251
[TBL] [Abstract][Full Text] [Related]
9. Association between human leukocyte antigen polymorphism and human papillomavirus 16-positive vulval intraepithelial neoplasia in British women.
Davidson EJ; Davidson JA; Sterling JC; Baldwin PJ; Kitchener HC; Stern PL
Cancer Res; 2003 Jan; 63(2):400-3. PubMed ID: 12543794
[TBL] [Abstract][Full Text] [Related]
10. Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women.
Cuzick J; Terry G; Ho L; Monaghan J; Lopes A; Clarkson P; Duncan I
Br J Cancer; 2000 Apr; 82(7):1348-52. PubMed ID: 10755413
[TBL] [Abstract][Full Text] [Related]
11. Major histocompatibility complex class II polymorphisms and risk of cervical cancer in Puerto Rican women.
Climent C; Nazario CM; Umpierre S; Quintero M; Gorbea S
P R Health Sci J; 2007 Jun; 26(2):97-101. PubMed ID: 17722421
[TBL] [Abstract][Full Text] [Related]
12. Predisposition to HPV16/18-related cervical cancer because of proline homozygosity at codon 72 of p53 among Indian women is influenced by HLA-B*07 and homozygosity of HLA-DQB1*03.
Bhattacharya P; Sengupta S
Tissue Antigens; 2007 Oct; 70(4):283-93. PubMed ID: 17767549
[TBL] [Abstract][Full Text] [Related]
13. Some but not all of HLA-II alleles are associated with cervical cancer in Chinese women.
Liang J; Xu A; Xie Y; Awonuga AO; Lin Z
Cancer Genet Cytogenet; 2008 Dec; 187(2):95-100. PubMed ID: 19027490
[TBL] [Abstract][Full Text] [Related]
14. Affected sib-pair analysis of the contribution of HLA class I and class II loci to development of cervical cancer.
Engelmark M; Beskow A; Magnusson J; Erlich H; Gyllensten U
Hum Mol Genet; 2004 Sep; 13(17):1951-8. PubMed ID: 15238505
[TBL] [Abstract][Full Text] [Related]
15. HPV16 E6 variants and HLA class II polymorphism among Chinese women with cervical cancer.
Wu Y; Liu B; Lin W; Xu Y; Li L; Zhang Y; Chen S; Xu A
J Med Virol; 2007 Apr; 79(4):439-46. PubMed ID: 17311339
[TBL] [Abstract][Full Text] [Related]
16. TP53 polymorphism, HPV infection, and risk of cervical cancer.
Klug SJ; Wilmotte R; Santos C; Almonte M; Herrero R; Guerrero I; Caceres E; Peixoto-Guimaraes D; Lenoir G; Hainaut P; Walboomers JM; Muñoz N
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):1009-12. PubMed ID: 11535556
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms for chemical metabolizing genes and risk for cervical neoplasia.
Sierra-Torres CH; Au WW; Arrastia CD; Cajas-Salazar N; Robazetti SC; Payne DA; Tyring SK
Environ Mol Mutagen; 2003; 41(1):69-76. PubMed ID: 12552594
[TBL] [Abstract][Full Text] [Related]
18. High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women.
Sasagawa T; Basha W; Yamazaki H; Inoue M
Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):45-52. PubMed ID: 11205488
[TBL] [Abstract][Full Text] [Related]
19. Variations in immunogenetics, human papillomavirus (HPV) infection & predisposition to cervical cancer in Indian women.
Gokhale P; Kerkar S; Tongaonkar H; Chaudhari H; Warke H; Salvi V; Mania-Pramanik J
Indian J Med Res; 2014 Nov; 140 Suppl(Suppl 1):S36-43. PubMed ID: 25673541
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms of GSTM1, p21, p53 and HPV infection with cervical cancer in Korean women.
Lee SA; Kim JW; Roh JW; Choi JY; Lee KM; Yoo KY; Song YS; Kang D
Gynecol Oncol; 2004 Apr; 93(1):14-8. PubMed ID: 15047208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
